North America Surgical Stapling Devices Market could be worth US$ 1,962.94 million by 2028,says Business Market Insights

The North America surgical stapling devices market was valued at US$ 1,962.94 million in 2022 and is projected to reach US$ 3,208.08 million by 2028. It is estimated to grow at a CAGR of 8.5% from 2022 to 2028. Analysis - by Product (Powered Surgical Staplers and Manual Surgical Staplers), Type (Disposable Surgical Staplers and Reusable Surgical Staplers), Application (Orthopedic Surgery, Endoscopic Surgery, Cardiac and Thoracic Surgery, Abdominal and Pelvic Surgery, and Others), and End User (Hospitals and Ambulatory Surgical Centers)

Get PDF Sample Report + All Related Table and Graphs @: https://www.businessmarketinsights.com/sample/BMIRE00028639?utm_source=OpenPR&utm_medium=10823

Competitive Landscape: North America Surgical Stapling Devices Market:
A significant rise in the number of surgical procedures performed at hospitals has compelled medical device manufacturers to develop and launch new products and obtain regulatory approvals for them. Major companies in the surgical stapling devices market allocate significant resources to research and development activities to come up with new offerings. For instance, In October 2022, Teleflex Incorporated completed the acquisition of Standard Bariatrics, Inc., which has commercialized an innovative powered stapling technology for bariatric surgery. Teleflex acquired Standard Bariatrics for US$ 170 million at closing, with additional consideration of up to US$ 130 million that is payable upon achieving certain commercial milestones. Similarly, in June 2022, Ethicon, a part of Johnson & Johnson MedTech, launched ECHELON 3000 Stapler in the US. It is a digitally enabled device that provides surgeons with simple, one-handed powered articulation to help address the unique needs of their patients. Designed with a 39% greater jaw aperture and a 27% larger articulation span, ECHELON 3000 gives surgeons better access and control over each transection, even in tight spaces and on challenging tissue. Combined with software that provides real-time haptic and audible device feedback, these features enable surgeons to make critical adjustments during procedures. An increase in the number of developments and launches of such innovative products, along with business acquisitions and collaborations, boosts the growth of the North America surgical stapling devices market.

3M Co
Braun SE
Conmed Corp
Ethicon USA LLC
Intutive Surgical Inc
Medtronic Plc
Bottom of Form

Chapter Details of North America Surgical Stapling Devices Market:
Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: North America Surgical Stapling Devices Market Landscape
Part 04: North America Surgical Stapling Devices Market Sizing
Part 05: North America Surgical Stapling Devices Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

Interested in Purchasing this Report? Click here @ https://www.businessmarketinsights.com/buy/BMIRE00028639?utm_source=OpenPR&utm_medium=10823

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sonam Patil
SE-mail: sales@permiummarketinsights.com
Phone: +1-646-491-9876

About Us:
Bussiness Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

This release was published on openPR.